Topic archive

regulatory context

5 stories

10/13/2026

Cannabis and psychedelics sector weekly roundup

Market Exclusive highlights recent developments in cannabis and psychedelics.

9/15/2026

Trump's mention of psychedelic therapies sparks renewed interest in their potential applications.

9/13/2026

FDA approval of psychedelics like ibogaine could influence Japanese pharmacy practices.

8/29/2026

David Dardashti's clinic highlights ten years of treating kratom addiction with ibogaine.

7/24/2026

Internal discussions focus on potential therapeutic uses and regulatory challenges.